Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

ERbeta-selektive agonists: Innovative therapy for treatment of cholangiocarcinoma

Reference number
Coordinator Karo Bio Aktiebolag
Funding from Vinnova SEK 75 000
Project duration January 2010 - April 2010
Status Completed

Last updated 25 November 2019

Reference number 2010-00872

Page statistics